SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-16-015306
Filing Date
2016-09-08
Accepted
2016-09-08 17:08:49
Documents
1
Period of Report
2016-08-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT p7247874.html 3  
1 OWNERSHIP DOCUMENT p7247874.xml 3 8583
  Complete submission text file 0000919574-16-015306.txt   11000
Mailing Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS LP (Reporting) CIK: 0001278386 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37648 | Film No.: 161876988

Mailing Address 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY 10019
Business Address 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD CAPITAL INC (Reporting) CIK: 0001278387 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37648 | Film No.: 161876987

Mailing Address
Business Address
BRADSHER NEAL C (Reporting) CIK: 0001278388 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37648 | Film No.: 161876986

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances